Understanding triclabendazole resistance (Q36776091)

16 August 2017

1 reference

title

Understanding triclabendazole resistance (English)

1 reference

16 August 2017

1 reference

G P Brennan

1

1 reference

16 August 2017

I Fairweather

2

1 reference

16 August 2017

A Trudgett

3

1 reference

16 August 2017

E Hoey

4

1 reference

16 August 2017

McCoy

5

1 reference

16 August 2017

M McConville

6

1 reference

16 August 2017

M Meaney

7

1 reference

16 August 2017

M Robinson

8

1 reference

16 August 2017

N McFerran

9

1 reference

16 August 2017

L Ryan

10

1 reference

16 August 2017

C Lanusse

11

1 reference

16 August 2017

L Mottier

12

1 reference

16 August 2017

L Alvarez

13

1 reference

16 August 2017

H Solana

14

1 reference

16 August 2017

G Virkel

15

1 reference

16 August 2017

P M Brophy

16

1 reference

16 August 2017

15 February 2007

1 reference

Experimental and Molecular Pathology

16 August 2017

1 reference

16 August 2017

82

1 reference

16 August 2017

2

1 reference

16 August 2017

104-109

1 reference

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Role of ABC transporters in veterinary drug research and parasite resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Lack of reversion in triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Triclabendazole: new skills to unravel an old(ish) enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Tubulin and FtsZ form a distinct family of GTPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Biochemical and molecular mechanisms of drug resistance in parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Resistance of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Genetic variability following selection of Haemonchus contortus with anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Molecular diagnosis of anthelmintic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

Drug resistance in veterinary helminths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.01.009

10.1016/J.YEXMP.2007.01.009

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference